Altimmune, Inc. (ALT) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Altimmune, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.316 Good morning, ladies and gentlemen, and welcome to the Altamune First Quarter 2026 Financial 00:00:04.316 -- 00:00:09.662 Results Conference Call. At this time, all participants are in a listen-only mode. 00:00:09.662 -- 00:00:12.646 After the speaker's presentation, there will be a question and answer session. 00:00:12.646 -- 00:00:18.312 To ask a question during the session, you'll need to press star 1 1 on your telephone. 00:00:18.312 -- 00:00:21.977 You will then hear an automated message advising your hand is raised. 00:00:21.977 -- 00:00:25.200 To withdraw your question, please press star 1 1 again. 00:00:25.200 -- 00:00:29.545 As a reminder, this call is being recorded. 00:00:29.545 -- 00:00:33.789 I'll now introduce your host for today's conference call, Luis Sine, Vice President of 00:00:33.789 -- 00:00:37.891 Investor Relations. Luis, you may begin. 00:00:37.933 -- 00:00:40.556 Thank you, operator, and good morning, everyone. 00:00:40.556 -- 00:00:45.561 Thank you for joining us for Altimmune's first quarter 2026 financial results 00:00:45.561 -- 00:00:50.666 and business update call. On today's call, you'll hear from Jerry Durso, our 00:00:50.666 -- 00:00:53.789 President and Chief Executive Officer, Dr. 00:00:53.789 -- 00:00:59.011 Christoph Arbid Engels, Chief Medical Officer, Linda Richardson, Chief Commercial 00:00:59.011 -- 00:01:03.377 Officer, and Greg Weaver, Chief Financial Officer. 00:01:03.377 -- 00:01:09.106 Following management's prepared remarks, we'll open the line for the Q&A session. 00:01:09.106 -- 00:01:14.274 Our first quarter 2026 earnings release was issued this morning and can be found 00:01:14.274 -- 00:01:17.859 on the investor relations section of our website. 00:01:17.859 -- 00:01:22.926 Before...